TAK1 was also under the transcription suppressor activity of miR-146a and miR-26b to promote gastric cancer cell apoptosis [135], attenuating NF-κB signaling, and potentiating the chemosensitivity of HCC [136], respectively. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.